Australia’s National Fuel Crisis Plan: What It Means for Your Business
When did you last fill up your car and wince at the total on the screen? For most Australians, that moment has become routine over the past several months. Petrol prices are…
When did you last fill up your car and wince at the total on the screen? For most Australians, that moment has become routine over the past several months. Petrol prices are…
The Ambitious Australia report, released 17 March 2026, proposes the most far-reaching restructure of the R&DTI since it replaced the R&D Tax Concession in 2011. The independent Strategic Examination of Research and…
“Razor gang” once meant something literal. In the 1920s, it described Sydney’s street thugs who swapped pistols for straight razors after the law clamped down on guns. The term returned in the…
Not all R&D Tax Incentive consultants are created equal, and this is the straight point and a summary of this blog post. Choosing the wrong consultant could cost you thousands of dollars…
Is Australia stuck in the ground? Even though it is a tough question, you must ask yourself this as a business owner in Australia. For decades, our national identity and our export…
Australia has long been known as the lucky country, rich in iron ore and coal, but a new class of minerals—those crucial to modern technology and defence—is rewriting our national story. Forget…
You wear more hats than a milliner if you are a small business owner, an entrepreneur, or a startup founder in Australia. You are the visionary, the accountant, the marketer, and often,…
When the Australian Renewable Energy Agency (ARENA) announced Round 2 of its Hydrogen Headstart Program, the reaction across the clean energy sector was a mix of excitement and urgency. Backed by a…
Australia has long been celebrated as a “clever country,” boasting world-class research capabilities with a substantial talent pool. But the Strategic Examination of R&D discussion paper reveals a critical challenge! The Department…
If you are in the biotech business or a biotech entrepreneur with a promising RNA therapeutic? You think you can transform patient outcomes, but you are stuck in the funding valley between…